Hakon Leffler
11 – 20 of 179
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis
- Contribution to journal › Article
-
Mark
Exploration into Galectin-3 Driven Endocytosis and Lattices
- Contribution to journal › Article
-
Mark
Discovery of the Selective and Orally Available Galectin-1 Inhibitor GB1908 as a Potential Treatment for Lung Cancer
- Contribution to journal › Article
-
Mark
Interplay of halogen bonding and solvation in protein-ligand binding
- Contribution to journal › Article
-
Mark
Determining the Affinity and Kinetics of Small Molecule Inhibitors of Galectin-1 Using Surface Plasmon Resonance
- Contribution to journal › Article
-
Mark
Myocardin related transcription factor and galectin-3 drives lipid accumulation in human blood vessels
- Contribution to journal › Article
-
Mark
Endocytic Roles of Glycans on Proteins and Lipids
- Contribution to journal › Article
- 2023
-
Mark
Increased synovial galectin-3 induce inflammatory fibroblast activation and osteoclastogenesis in patients with rheumatoid arthritis
- Contribution to journal › Article
-
Mark
Increased Galectin-9 Levels Correlate with Disease Activity in Patients with DMARD-Naïve Rheumatoid Arthritis and Modulate the Secretion of MCP-1 and IL-6 from Synovial Fibroblasts
- Contribution to journal › Article
-
Mark
Strong Binding of C-Glycosylic1,2-Thiodisaccharides to Galectin-3─Enthalpy-Driven Affinity Enhancement by Water-Mediated Hydrogen Bonds
- Contribution to journal › Article
